Intrinsic breast cancer subtypes defined by estrogen receptor signalling—prognostic relevance of progesterone receptor loss
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intrinsic breast cancer subtypes defined by estrogen receptor signalling—prognostic relevance of progesterone receptor loss
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 26, Issue 9, Pages 1161-1171
Publisher
Springer Nature
Online
2013-04-05
DOI
10.1038/modpathol.2013.60
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study
- (2012) Alina Vrieling et al. BREAST CANCER RESEARCH AND TREATMENT
- Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer
- (2012) S Barton et al. BRITISH JOURNAL OF CANCER
- How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
- (2012) Zsuzsanna Varga et al. PLoS One
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
- (2011) Peter A Fasching et al. BMC CANCER
- Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization
- (2011) Kuo-Jang Kao et al. BMC CANCER
- Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
- (2011) E K A Millar et al. BRITISH JOURNAL OF CANCER
- Forkhead box A1 (FOXA1) is a key mediator of insulin-like growth factor I (IGF-I) activity
- (2011) Adam S. Potter et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Serum Enterolactone and Prognosis of Postmenopausal Breast Cancer
- (2011) Katharina Buck et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Aromatase, aromatase inhibitors, and breast cancer
- (2011) Saranya Chumsri et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer molecular profiling with single sample predictors: a retrospective analysis
- (2010) Britta Weigelt et al. LANCET ONCOLOGY
- Molecular therapy of breast cancer: progress and future directions
- (2010) Sheng-Xiang Lin et al. Nature Reviews Endocrinology
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications
- (2008) S Badve et al. JOURNAL OF CLINICAL PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started